Cargando…
Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients
Background: Although useful in the time-race against COVID-19, CPAP cannot provide oxygen over the physiological limits imposed by severe pulmonary impairments. In previous studies, we reported that the administration of the SLAB51 probiotics reduced risk of developing respiratory failure in severe...
Autores principales: | Trinchieri, Vito, Marazzato, Massimiliano, Ceccarelli, Giancarlo, Lombardi, Francesca, Piccirilli, Alessandra, Santinelli, Letizia, Maddaloni, Luca, Vassalini, Paolo, Mastroianni, Claudio Maria, d’Ettorre, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405060/ https://www.ncbi.nlm.nih.gov/pubmed/36009399 http://dx.doi.org/10.3390/biomedicines10081851 |
Ejemplares similares
-
Oxygen Sparing Effect of Bacteriotherapy in COVID-19
por: Ceccarelli, Giancarlo, et al.
Publicado: (2021) -
Health-related quality of life in survivors of severe COVID-19 infection
por: d’Ettorre, Gabriele, et al.
Publicado: (2022) -
Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
por: Santinelli, Letizia, et al.
Publicado: (2022) -
Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021) -
Dysbiosis in SARS-CoV-2–Infected Patients
por: Marazzato, Massimiliano, et al.
Publicado: (2021)